United States News All stories

Jade Biosciences (NASDAQ:JBIO) reported preclinical results for JADE301, an investigational antibody targeting dermatomyositis, at the European Academy of Dermatology and Venereology Congress in Vienna.

Connect Biopharma (NASDAQ:CNTB) reported preliminary Phase 2 results showing that investigational rademikibart reduced treatment failure in adults with acute chronic obstructive pulmonary disease (COPD) exacerbations and type 2 inflammation.

NRx Pharmaceuticals (NASDAQ:NRXP) announced that its subsidiary NRx Defense Systems received an initial DARPA prime contract worth $11,177,757.27 to evaluate a treatment approach for major depressive disorder.

Atara Biotherapeutics (NASDAQ:ATRA) announced that partner Pierre Fabre Pharmaceuticals resubmitted the Biologics License Application (BLA) for tabelecleucel to the U.S. Food and Drug Administration for treatment of relapsed or refractory EBV-positive post-transplant lymphoproliferative disease.

Cerenome (NASDAQ:CNSY) reported unaudited third-quarter 2026 gross payer billings of $1.55 million from 222 tests performed by its wholly owned CNSide Diagnostics subsidiary.

KIDZ AI (NASDAQ:KIDZ) submitted a procurement inquiry to Tesla for an initial 500 Robotaxis as part of a preliminary plan to explore an autonomous vehicle fleet strategy.

RedCloud (NASDAQ:RCT) reported revenue of $24 million for the six months ended June 30, 2026, an increase of 34% year over year, as total trading volume increased to $1.56 billion.

Ten-League International Holdings (NASDAQ:TLIH) reported unaudited first-half 2026 revenue of S$33.1 million for the six months ended June 30, 2026, with revenue declining as equipment and parts sales decreased.

Rich Sparkle Holdings (NASDAQ:ANPA) reported unaudited revenue of US$2.12 million for the six months ended March 31, 2026, representing a 21.8% increase compared with the prior-year period.

Sarepta Therapeutics (NASDAQ:SRPT) presented new clinical data showing ELEVIDYS (delandistrogene moxeparvovec) was associated with functional benefits in older ambulatory patients with Duchenne muscular dystrophy at the World Muscle Society Congress 2026.

Recon Technology (NASDAQ:RCON) reported fiscal 2026 revenue of RMB109.9 million for the year ended June 30, 2026, an increase of 65.8% from the prior fiscal year.

OSI Systems (NASDAQ:OSIS) announced that its Security division received orders totaling approximately $23 million from a North America customer to provide civil works, service and support for cargo inspection systems.

Novo Nordisk (NYSE:NVO) presented new CagriSema clinical data at EASD 2026, including studies evaluating food-related brain responses, organ fat changes and weight reduction in adults with overweight or obesity.

Merck (NYSE:MRK) reported Phase 2b MK-7240-012 trial results showing investigational tulisokibart achieved the primary endpoint of Hidradenitis Suppurativa Clinical Response 50 (HiSCR50) at Week 16 in patients with moderate to severe hidradenitis suppurativa.

HomesToLife (NASDAQ:HTLM) reported unaudited first-half 2026 net revenue of US$198.3 million, up 10% year over year as export sales increased and retail sales expanded.

Eli Lilly (NYSE:LLY) reported Phase 3b ADtouch study results showing EBGLYSS monotherapy met its primary and secondary endpoints in adults and adolescents with hand-and-foot atopic dermatitis.

HPE (NYSE:HPE) announced a $1.2 billion order from Vultr for the deployment of AMD Helios AI Rack by HPE systems across Vultr’s U.S. cloud data center locations.

GE Vernova (NYSE:GEV) announced that its Board of Directors declared a quarterly dividend of $0.50 per share, with payment scheduled for November 24, 2026.

Jabil (NYSE:JBL) reported preliminary unaudited fiscal fourth-quarter 2026 revenue of $10.6 billion, with U.S. GAAP operating income of $602 million and diluted earnings per share of $3.76.

Conagra Brands (NYSE:CAG) reported fiscal 2027 first-quarter net income of $174 million, up 6% year over year, as earnings increased despite a 1.4% decline in net sales to $2.6 billion.

Sono-Tek (NASDAQ:SOTK) received three purchase orders totaling approximately $7.19 million from an existing clean energy customer for production-scale coating systems used in advanced solar manufacturing.

FactSet (NYSE:FDS) reported fourth-quarter fiscal 2026 revenue of $634.7 million for the period ended August 31, 2026, with subscription growth contributing to higher revenue while GAAP earnings declined.

Beamr Imaging (NASDAQ:BMR) expects fiscal year 2026 revenue of approximately $4.5 million, representing an estimated increase of about $1.5 million, or 50%, from fiscal year 2025.

Capital Bancorp (NASDAQ:CBNK) agreed to merge into Peoples Bancorp (NASDAQ:PEBO) in an all-stock transaction valued at approximately $728.1 million, creating a combined banking franchise with expanded commercial and specialty lending operations.